Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Spectra Therapy, LLC.
WARNING LETTER
•Spectra Therapy, LLC.•September 13, 2024

Spectra Therapy, LLC. – FDA Warning Letter, Sep 13, 2024

Record Details

The FDA issued a warning letter to the company located at 3350 Lapeer Road, Port Huron, MI, following an inspection from September 10-13, 2024. The firm manufactures therapeutic heating infrared lamps, marketed as the LASERwrap system, which includes the Spectra A-100 Impulse Laser Unit and accessories. These products are classified as medical devices under the Federal Food, Drug, and Cosmetic Act.

The inspection revealed significant violations of the Quality System Regulation, specifically under 21 CFR Part 820. Key issues included the failure to establish and maintain adequate design control procedures, as required by 21 CFR § 820.30. The company lacked detailed procedures to ensure the design specifications were met and failed to verify or validate design changes, such as those made to the A-100 Impulse Laser unit housing.

Additionally, the firm did not have procedures to manage nonconforming products, as required by 21 CFR § 820.90. Nonconforming lasers were inadequately documented and managed, with no formal investigation or documentation process in place.

The company also failed to implement corrective and preventive action procedures, as outlined in 21 CFR § 820.100, and did not maintain adequate records of investigations, violating 21 CFR § 820.198(e). Furthermore, the firm did not properly evaluate and select suppliers based on their ability to meet quality requirements, as required by 21 CFR § 820.50(a)(1).

The FDA deemed the firm"s response to these violations inadequate and requested a comprehensive corrective action plan, including the establishment of design control procedures, documentation of nonconformance management, and implementation of a corrective and preventive action procedure. The firm must also provide a timeline for these actions and ensure compliance with regulatory requirements.

Company
Spectra Therapy, LLC.
Inspection date
September 13, 2024
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Matthew G. Hillebrenner
  • Gina Brackett (Director of Compliance Branch)
  • Sean Moynihan
View Company Profile

ID · dd880000-b732-462f-8924-8bb1b4216fed

Violation Codes10
21 CFR 820.30(a)21 CFR 803.1721 CFR 82021 CFR 820.2221 CFR 803.17(a)(1)21 CFR 803.17(a)(2)21 CFR 803.17(a)(3)21 CFR 803.321 CFR 803.20(c)(1)21 CFR 803.50(a)

Full citation text and observation details available on the Dashboard.

Other documents for Spectra Therapy, LLC.
  • 483 - 2024-09-13September 13, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Spectra Therapy, LLC.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.